Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Rep. Katie Porter (D-Calif.)—minus her "Whiteboard of Justice"—speaks at the U.S. Capitol on December 19, 2019. (Photo: Alex Wong/Getty Images)

Rep. Katie Porter (D-Calif.)—minus her "Whiteboard of Justice"—speaks at the U.S. Capitol on December 19, 2019. (Photo: Alex Wong/Getty Images) 

'You Lie': Katie Porter Wields 'Whiteboard of Justice' While Grilling Pharma CEO on Price Hikes

"You're spending all this money to make sure you make money rather than spending money to... help patients," the California congresswoman told AbbVie's Richard Gonzalez. 

U.S. lawmakers on Tuesday took the CEO of the maker of the world's bestselling drug to task for high product prices, with Rep. Katie Porter using her famed "Whiteboard of Justice" to demonstrate what she called "the Big Pharma fairy tale" that pharmaceutical research and development costs justify perpetual price hikes.

"The Big Pharma fairy tale is one of groundbreaking R&D that justifies astronomical prices. But the pharma reality is that you spend most of your company's money making money for yourself and your shareholders."
—Rep. Katie Porter

Members of the House Oversight Committee grilled AbbVie CEO Richard Gonzalez—whose total compensation topped $24 million last year (pdf)—about the reasons for increasing the price of its top-selling drug Humira to $77,000 for a year's supply.

Humira (adalimumab) is an immunosuppressant used to treat a wide range of inflammatory conditions including arthritis, Crohn's disease, psoriasis, and ulcerative colitis. Last year, Humira sales neared $20 billion, making it by far the world's bestselling pharmaceutical drug. 

In January, Fortune reported AbbVie would raise the price of Humira by 7.4%. Why the increase? Drugmakers often claim higher prices are needed to fund research and development. AbbVie spent a total of $2.45 billion on R&D from 2013 to 2018.

Porter (D-Calif.) pointed out that the company spends nearly double that—$4.7 billion—annually on advertising. 

When Porter asked Gonzalez how much the company compensates its executives, the CEO said, "About $60 million a year."

"Try $334 [million] on for size," Porter shot back.

Noting that AbbVie spent around $50 billion on cumulative stock buybacks and dividends from 2013 to 2018, Porter then told Gonzalez: "You're spending all this money to make sure you make money rather than spending money to invest in [and] develop drugs and help patients with affordable, lifesaving drugs."

"You lie to patients when you charge them twice as much for an unimproved drug, and then you lie to policymakers when you tell us that R&D justifies those price increases," Porter asserted.

"The Big Pharma fairy tale is one of groundbreaking R&D that justifies astronomical prices," she said. "But the pharma reality is that you spend most of your company's money making money for yourself and your shareholders."

"The fact [is] that you're not honest about that with patients and policymakers—that you're feeding us lies that we must pay astronomical prices to get 'innovative' treatments," added Porter. "The American people, the patients, deserve so much better."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
We need your help.

Support progressive journalism.

Common Dreams is not your average news site. We don't survive on clicks or advertising dollars. We rely entirely on your support. And without it, our independent progressive journalism simply wouldn’t exist. Every gift of every amount matters.

Join the fight and support our common dreams today.

Sanders Rips GOP for Remaining 'Loyal to the Big Lie,' Says Filibuster Must Be Abolished

"Not a single Republican in the United States Senate has the courage to even debate whether we should protect American democracy or not."

Jake Johnson, staff writer ·


'The Filibuster Must Go': Senate GOP Blocks Debate on Voting Rights Bill

"Democrats in the Senate can have a functional democracy or the filibuster, but not both."

Jessica Corbett, staff writer ·


Key Senate Democrat Applauded for Manifesto on Reducing Drug Costs

"Sen. Wyden's drug pricing principles are a road map for taking on the greed of pharmaceutical corporations and lowering drug prices for all Americans."

Jessica Corbett, staff writer ·



Coalition of 200+ Groups Call for Permanent End to 'Neocolonialist' Global Gag Rule

"The global community deserves true partnership from the U.S., but the threat that this destructive policy could reemerge undermines relationships and harms people around the globe."

Julia Conley, staff writer ·